Dbv Technologies Sa · EURONEXT:DBV
Raymond Debbane reported a 7.80% stake in Dbv Technologies Sa (Schedule 13G)
Event Oct 6, 2025 · Filed Oct 14, 2025
Raymond Debbane reported a 7.80% stake in Dbv Technologies Sa, 11,538,460 shares, as a passive investor on Oct 6, 2025. Filed Oct 14, 2025 (Schedule 13G).
- Stake
- 7.80%
- Shares
- 11,538,460
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Invus Public Equities, L.P. | 7.00% | 10,438,485 |
| Invus Public Equities Advisors, LLC | 7.00% | 10,438,485 |
| Invus Global Management, LLC | 7.00% | 10,438,485 |
| Siren, L.L.C. | 7.00% | 10,438,485 |
| Avicenna Life Sci Master Fund LP | 0.70% | 1,099,975 |
| Avicenna Life Sci Master GP LLC | 0.70% | 1,099,975 |
| Ulys, L.L.C. | 0.70% | 1,099,975 |
| Raymond Debbane | 7.80% | 11,538,460 |
Source
Related
- Dbv Technologies Sa
- Invus Public Equities, L.P.
- Dbv Technologies Sa shareholders
- Schedule 13G/A · Invus Public Equities, L.P. · May 5, 2026
- Schedule 13G/A · Invus Public Equities, L.P. · Feb 13, 2026
- AMF threshold crossing notice · J.P. Morgan Chase & Co. · Oct 19, 2026
- AMF threshold crossing notice · J.P. Morgan Chase & Co. · Oct 13, 2026
- Schedule 13G/A · Mpm Bioimpact LLC · Aug 14, 2026
- Schedule 13G · Ra Capital Management, L.P. · Aug 6, 2026
- Form 4 · Mohideen Pharis · Jul 31, 2026